194 related articles for article (PubMed ID: 24352760)
21. Cytomegalovirus and brain tumor: epidemiology, biology and therapeutic aspects.
Cobbs CS
Curr Opin Oncol; 2013 Nov; 25(6):682-8. PubMed ID: 24097102
[TBL] [Abstract][Full Text] [Related]
22. Human Papillomavirus and Human Cytomegalovirus Infection and Association with Prognosis in Patients with Primary Glioblastoma in Pakistan.
Adnan Ali SM; Mirza Y; Ahmad Z; Zahid N; Enam SA
World Neurosurg; 2019 Jan; 121():e931-e939. PubMed ID: 30321676
[TBL] [Abstract][Full Text] [Related]
23. Correlation between Rho-kinase pathway gene expressions and development and progression of glioblastoma multiforme.
Erkutlu I; Cigiloglu A; Kalender ME; Alptekin M; Demiryurek AT; Suner A; Ozkaya E; Ulasli M; Camci C
Tumour Biol; 2013 Apr; 34(2):1139-44. PubMed ID: 23338717
[TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor binding protein-2 and glucose-regulated protein 78 kDa: Potential biomarkers affect prognosis in IDH-wildtype glioblastoma patients.
Harland AJ; Perks CM; White P; Kurian KM; Barber HR
Cancer Med; 2023 Jul; 12(13):14426-14439. PubMed ID: 37212470
[TBL] [Abstract][Full Text] [Related]
25. EZH2-Myc driven glioblastoma elicited by cytomegalovirus infection of human astrocytes.
El Baba R; Pasquereau S; Haidar Ahmad S; Monnien F; Abad M; Bibeau F; Herbein G
Oncogene; 2023 Jun; 42(24):2031-2045. PubMed ID: 37147437
[TBL] [Abstract][Full Text] [Related]
26. Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival.
Rahbar A; Orrego A; Peredo I; Dzabic M; Wolmer-Solberg N; Strååt K; Stragliotto G; Söderberg-Nauclér C
J Clin Virol; 2013 May; 57(1):36-42. PubMed ID: 23391370
[TBL] [Abstract][Full Text] [Related]
27. Multimodal techniques failed to detect cytomegalovirus in human glioblastoma samples.
Loit MP; Adle-Biassette H; Bouazza S; Mazeron MC; Manivet P; Lehmann-Che J; Teissier N; Mandonnet E; Molina JM
J Neurovirol; 2019 Feb; 25(1):50-56. PubMed ID: 30397828
[TBL] [Abstract][Full Text] [Related]
28. Human cytomegalovirus induces cellular tyrosine kinase signaling and promotes glioma cell invasiveness.
Cobbs CS; Soroceanu L; Denham S; Zhang W; Britt WJ; Pieper R; Kraus MH
J Neurooncol; 2007 Dec; 85(3):271-80. PubMed ID: 17589804
[TBL] [Abstract][Full Text] [Related]
29. Human cytomegalovirus-mediated immunomodulation: Effects on glioblastoma progression.
Foster H; Ulasov IV; Cobbs CS
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):273-276. PubMed ID: 28554666
[TBL] [Abstract][Full Text] [Related]
30. Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity.
Cobbs CS; Soroceanu L; Denham S; Zhang W; Kraus MH
Cancer Res; 2008 Feb; 68(3):724-30. PubMed ID: 18245472
[TBL] [Abstract][Full Text] [Related]
31. Discordant humoral and cellular immune responses to
Rahbar A; Peredo I; Solberg NW; Taher C; Dzabic M; Xu X; Skarman P; Fornara O; Tammik C; Yaiw K; Wilhelmi V; Assinger A; Stragliotto G; Söderberg-Naucler C
Oncoimmunology; 2015 Feb; 4(2):e982391. PubMed ID: 25949880
[No Abstract] [Full Text] [Related]
32. Cytomegalovirus infection induces a stem cell phenotype in human primary glioblastoma cells: prognostic significance and biological impact.
Fornara O; Bartek J; Rahbar A; Odeberg J; Khan Z; Peredo I; Hamerlik P; Bartek J; Stragliotto G; Landázuri N; Söderberg-Nauclér C
Cell Death Differ; 2016 Feb; 23(2):261-9. PubMed ID: 26138445
[TBL] [Abstract][Full Text] [Related]
33. Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes.
Wang H; Wang H; Shen W; Huang H; Hu L; Ramdas L; Zhou YH; Liao WS; Fuller GN; Zhang W
Cancer Res; 2003 Aug; 63(15):4315-21. PubMed ID: 12907597
[TBL] [Abstract][Full Text] [Related]
34. Evolving evidence implicates cytomegalovirus as a promoter of malignant glioma pathogenesis.
Cobbs CS
Herpesviridae; 2011 Oct; 2(1):10. PubMed ID: 22030012
[TBL] [Abstract][Full Text] [Related]
35. Detection of circulating hcmv-miR-UL112-3p in patients with glioblastoma, rheumatoid arthritis, diabetes mellitus and healthy controls.
Mohammad AA; Rahbar A; Lui WO; Davoudi B; Catrina A; Stragliotto G; Mellbin L; Hamsten A; Rydén L; Yaiw KC; Söderberg-Nauclér C
PLoS One; 2014; 9(12):e113740. PubMed ID: 25462570
[TBL] [Abstract][Full Text] [Related]
36. HCMV-encoded miR-UL112-3p promotes glioblastoma progression via tumour suppressor candidate 3.
Liang Q; Wang K; Wang B; Cai Q
Sci Rep; 2017 Mar; 7():44705. PubMed ID: 28303930
[TBL] [Abstract][Full Text] [Related]
37. Human Cytomegalovirus DNA among Women with Breast Cancer.
Sepahvand P; Makvandi M; Samarbafzadeh A; Talaei-Zadeh A; Ranjbari N; Nisi N; Azaran A; Jalilian S; Pirmoradi R; Makvandi K; Ahmadi Angali K
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2275-2279. PubMed ID: 31450895
[TBL] [Abstract][Full Text] [Related]
38. Expression of cytomegalovirus in glioblastoma multiforme: Myth or reality?
Taha MS; Abdalhamid BA; El-Badawy SA; Sorour YM; Almsned FM; Al-Abbadi MA
Br J Neurosurg; 2016 Jun; 30(3):307-12. PubMed ID: 26742571
[TBL] [Abstract][Full Text] [Related]
39. Investigation of serum levels and tissue expression of two genes IGFBP-2 and IGFBP-3 act as potential biomarker for predicting the progression and survival in patients with glioblastoma multiforme.
Abdolhoseinpour H; Mehrabi F; Shahraki K; Khoshnood RJ; Masoumi B; Yahaghi E; Goudarzi PK
J Neurol Sci; 2016 Jul; 366():202-206. PubMed ID: 27288807
[TBL] [Abstract][Full Text] [Related]
40. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
